AbbVie acquires Botox-maker Allergan in ‘turning point’ deal

Published: 15-May-2020

The acquisition will see AbbVie achieve approximately US$30bn in full-year 2020 revenues

You need to be a subscriber to read this article.
Click here to find out more.

You may also like